Teligene
PrivateLast Round
Series C
Feb 22, 2021
Total Funding Raised
$103.49M
Company Overview
Teligene is a biotechnology company that develops small-molecule targeted innovative drugs for the treatment of various types of cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoveryoncology therapeuticssmall-molecule drugstargeted therapyHDAC inhibitorsEGFR inhibitorsALK inhibitorsBRAF inhibitorsbiopharmapreclinical developmentdrug pipelinemedicinal chemistrycancer researchdrug licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teligene Comparables
Compare Teligene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen TargetRx | 86% | |
| Shengke Pharmaceuticals (Jiangsu) Ltd. | 83% | |
| Suzhou Genhouse Bio Co., Ltd. | 83% | |
Teligene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 22, 2021 | ||||
| Series A | Jul 6, 2017 |
Teligene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series C |
| IDG Capital | Series C |
| Mirae Asset | Series C |
| China International Capital Corporation | Series C |
| Hankang Capital | Series A |
| Shenzhen Capital Group | Series A |
Teligene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Teligene's valuation, stock price, and market status.
Firmographic Details
HeadquartersSuzhou
Employee Range2
Year Founded2011
Last FundingFeb 22, 2021